ArticleMedicine2026
Global, regional, and national epidemiology of leukemia in children from 1990 to 2021: A cross-sectional study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Childhood leukemia remains a critical global public health challenge, contributing significantly to disability and premature mortality. Despite progress in healthcare, comprehensive estimates of its burden across geographic and sociodemographic strata remain essential for formulating evidence-based interventions. Utilizing data from the Global Burden of Diseases 2021, this cross-sectional study analyzed leukemia incidence, deaths, and disability-adjusted life years (DALYs) among children aged 0 to 14 across 204 countries and territories from 1990 to 2021. Stratified analyses by region, nation, age, sex, leukemia type, and Sociodemographic Index (SDI) were conducted, with estimated annual percentage changes calculated to assess trends. In 2021, childhood leukemia caused 58,785 incident cases (95% uncertainty interval [UI], 43,200-73,139), 27,861 deaths, and 2,341,610 DALYs globally, corresponding to an incidence rate of 4.37 per 100,000 (95% UI, 3.51-5.46). From 1990 to 2021, global incidence and death rates declined by a total of 0.23% (95% UI, -0.44% to -0.11%) and 0.52% (95% UI, -0.64% to -0.35%), respectively. However, the low-SDI region exhibited rising incidence, mortality, and DALY rates. Australasia experienced the largest incidence increase (estimated annual percentage change: 0.67%, 95% confidence interval, 0.23%-1.11%). Nationally, San Marino reported the highest incidence (13.79 per 100,000; 95% UI, 8.03-21.07), while Tokelau had the highest mortality (7.92 per 100,000; 95% UI, 4.36-13.32) and DALY rates (116.39 per 100,000; 95% UI, 86.46-139.97). Despite global reductions in childhood leukemia burden over 3 decades, persistent disparities across SDI subgroups and regions underscore unmet needs in low-resource settings. Precision epidemiology and context-specific strategies are imperative to mitigate inequities and optimize prevention and care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.